Skip to main content

AS/Spondyloarthritis

      RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by @Novartis. All content chosen by Rh
      4 years ago
      RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.
      Importance of Central Imaging Reads in SpA: Dr. Eric Ruderman

      Dr. Eric Ruderman examines Abstract #0447 about the difference in local vs. central imaging reads, as presented at the 2020 ACR annual meeting.

      Better outcomes (ASAS20 and ASAS40 @wk 52) seen in younger pts (possibly lower disease duration) when Secukinumab was gi
      4 years ago
      Better outcomes (ASAS20 and ASAS40 @wk 52) seen in younger pts (possibly lower disease duration) when Secukinumab was given to ankylosing spondylitis pts. Early Dx in #AS! #ACR20 Abstr#0350 https://t.co/EKks0b1upc https://t.co/bxIH9lloI1
      RT @bella_mehta: Emerging trend #MachineLearning - SpA expert Dr Dennis Poddubnyy talks at #ACR20 press conference - Dev
      4 years ago
      Emerging trend #MachineLearning - SpA expert Dr Dennis Poddubnyy talks at #ACR20 press conference - Development and Validation of an #artificial_intelligence Approach for the Detection of Radiographic Sacroiliitis using MRI @RheumNow
      RT @Janetbirdope: Who will be more likely to have chronic reactive arthritis @RheumNow #ACR20 @CRASCRRheum
      4 years ago
      Who will be more likely to have chronic reactive arthritis @RheumNow #ACR20 @CRASCRRheum
      RT @RHEUMarampa: ACHILLES study: Only 56% of pts w/ clinical enthesitis had MRI+ heel enthesitis. MRI screening: HLAB27+
      4 years ago
      ACHILLES study: Only 56% of pts w/ clinical enthesitis had MRI+ heel enthesitis. MRI screening: HLAB27+ pts likely to be in MRI+ grp. @RheumNow #ACR20 Abstr#0447 #ACRbest https://t.co/m2cjDzYfyg
      RT @RHEUMarampa: Dr.Gonzalez-Mazon describes surrogate markers assoc'd w #atherosclerosis in #axSpA: BASFI, BASMI, IBD,
      4 years ago
      Dr.Gonzalez-Mazon describes surrogate markers assoc'd w #atherosclerosis in #axSpA: BASFI, BASMI, IBD, ESR, CRP, prednisone and DMARDs use. @RheumNow #ACR20 abst#0448 https://t.co/g27qA4qpPL
      RT @doctorRBC: Extended 5 year study of secukinumab in AS patients showed sustained improvement of back pain, nocturnal

      Extended 5 year study of secukinumab in AS patients showed sustained improvement of back pain, nocturnal back pain, AM stiffness, fatigue and LDA Abs#0364 @RheumNow #ACR20